Xenopus laevis Toxicity Assay
Creative Biolabs is at the forefront of scientific innovation, offering a wide range of cutting-edge services in the field of neuroscience. One of our key areas of expertise lies in the development and application of Xenopus laevis toxicity assays, which play a crucial role in evaluating the potential neurotoxic effects of various substances. With over 20 years of experience in the industry, our team of highly skilled biological experts combines their knowledge and expertise to deliver exceptional services that meet the diverse needs of our clients.
Xenopus laevis Teratogenesis Assay (FETAX)
The Xenopus laevis Teratogenesis Assay, also known as FETAX (Frog Embryo Teratogenesis Assay-Xenopus), is a well-established and widely used method for assessing the toxic effects of chemical compounds on early vertebrate development. This assay utilizes the African clawed frog, Xenopus laevis, as a model organism due to its physiological and developmental similarities to humans. FETAX has proven to be a valuable tool in neurotoxicity testing, providing crucial insights into the potential hazards of substances on the nervous system.
The FETAX assay involves exposing Xenopus laevis embryos to test compounds during their early developmental stages. The embryos are typically obtained from in vitro fertilization and are maintained in a controlled environment throughout the assay. Various endpoints are evaluated, including mortality, malformations, and developmental abnormalities, allowing for a comprehensive assessment of the compound's toxicity.
Figure 1: FETAX Assay in Drug development with Xenopus laevis. (Saide, 2020)
FETAX Workflow
The Xenopus laevis Toxicity Assay follows a well-defined workflow, ensuring standardized and reproducible results. The key steps involved in the assay are as follows:
Applications
The Xenopus laevis toxicity assay has a wide range of applications in the field of toxicology and drug discovery. Here are some key areas where this assay has proven to be invaluable:
The FETAX assay allows researchers to evaluate the potential teratogenic effects of chemical compounds. By exposing Xenopus laevis embryos to different concentrations of a test compound, researchers can determine its impact on embryonic development. This information is crucial for identifying compounds that may pose risks to human development and reproductive health.
The FETAX assay is also employed in drug screening programs to evaluate the potential toxicity of candidate compounds during early stages of drug development. By assessing the effects of compounds on embryonic development, researchers can identify potential safety concerns and prioritize compounds with favorable toxicological profiles for further investigation.
In addition to assessing toxicity, the FETAX assay can provide valuable insights into the mechanism of action of the tested substances. By observing the developmental defects and abnormalities caused by the chemicals, researchers can gain a better understanding of how these substances interfere with normal development processes.
Please feel free to contact us for more about our Xenopus laevis models related services.
Reference
- Saide, Katy, and Grant N. Wheeler. "In vivo assessment of drug-induced hepatotoxicity using Xenopus embryos." Cold Spring Harbor Protocols 2020.11 (2020): pdb-prot106096.

- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)